Suicidal and self-injurious behavior following adalimumab reference-to-generic biosimilar switch.

Ward, Catherine; Farag, Mena; Pollak, Thomas A; Coutinho, Ester; Posporelis, Sotiris

Ward, Catherine; Farag, Mena; Pollak, Thomas A; Coutinho, Ester; Posporelis, Sotiris.

Afiliación

Ward C; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.
Farag M; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.
Pollak TA; King's College Hospital NHS Foundation Trust, King's College Hospital, London, UK.
Coutinho E; South London and Maudsley NHS Foundation Trust, Maudsley Hospital, London, UK.
Posporelis S; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Psychiatry Clin Neurosci ; 76(2): 59-62, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34792254

Asunto(s)

Biosimilares Farmacéuticos; Sustitución de Medicamentos; Conducta Autodestructiva; Adalimumab; Adulto; Medicamentos Genéricos; Humanos; Masculino; Ideación Suicida

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Conducta Autodestructiva / Sustitución de Medicamentos / Biosimilares Farmacéuticos Límite: Adult / Humans / Male Idioma: En Revista: Psychiatry Clin Neurosci Asunto de la revista: NEUROLOGIA / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google